NK Cell Therapy Could Bring Advanced Cancer Treatment to Community Clinics
Indapta Therapeutics reports 90%+ tumor marker reduction in early trials—without the dangerous side effects of CAR T-cell therapies.
Indapta Therapeutics reports 90%+ tumor marker reduction in early trials—without the dangerous side effects of CAR T-cell therapies.
Dr. Mark Frohlich never set out to build a lean [...]
When Bruno Basso stepped off the plane in Michigan as [...]
In this episode, we talk with Dr. Mark Frohlich, CEO of Indapta Therapeutics, a biotech company working to make cancer treatment safer, more effective, and more accessible.
In a world awash with data, the most valuable innovations [...]
Built on MSU technology, Bruno Basso’s company CIBO Technologies helps global brands turn agricultural data into measurable environmental outcomes.
(January-March 2025) MSU Research Foundation backs a diverse range of startups through its Red Cedar Ventures and Michigan Rise Pre-Seed III investment funds, supporting companies in healthcare, fintech, education mobility and more.
In part two of our conversation with Bruno Basso, professor at Michigan State University and co-founder of CIBO Technologies, we explore what it takes to scale scientific innovation into a venture-backed company.
Hosted by the MSU Research Foundation, the event showcased Michigan’s leadership in advanced packaging and brought together regional partners to explore innovation, public-private collaboration, and the future of materials recovery and reuse.
(January-March 2025) MSU Research Foundation welcomed three startup businesses to incubator facilities in East Lansing. Companies specializing in medical devices, neonatal care, and protein therapeutics add to the region’s growing high-tech innovation ecosystem.